Zenas Biopharma revenue was $5.00M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $5.0M, up Infinity% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ZBIO annual revenue was $5.0M, with -90% growth year-over-year.
ZBIO past revenue growth
How has ZBIO's revenue growth performed historically?
Zenas Biopharma (NASDAQ: ZBIO) reported Q4 2024 revenue of $5.00 million up Infinity% year over year. In the same quarter last year, Zenas Biopharma's revenue was $0.00.
What was Zenas Biopharma's revenue in 2024?
Zenas Biopharma's annual revenue for the twelve months ending Dec 31, 2024 was $5.00 million, a 90% decrease year over year.
How much does Zenas Biopharma make in a day?
Based on Zenas Biopharma annual revenue for the past two years, ZBIO makes an average of $75,342.47 per day.
What was Zenas Biopharma's annual revenue growth in the past year?
As of Q2 2025, Zenas Biopharma's revenue has grown -90% year over year. This is 527.31 percentage points lower than the US Biotechnology industry revenue growth rate of 437.31%. Zenas Biopharma's revenue in the past year totaled $5.00 million.
How much does Zenas Biopharma make in a year?
Zenas Biopharma's revenue by year for the past two years is:
Zenas Biopharma's revenue for the twelve months ending Dec 31, 2024 was $5.00 million, a 90% decrease year over year.
Zenas Biopharma's annual revenue for Dec 31, 2023 was $50.00 million, a Infinity% increase from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.